Your browser doesn't support javascript.
loading
Phenotypic clustering of patients hospitalized in intensive cardiac care units: Insights from the ADDICT-ICCU study.
Hamzi, Kenza; Gall, Emmanuel; Roubille, François; Trimaille, Antonin; Elbaz, Meyer; El Ouahidi, Amine; Noirclerc, Nathalie; Fard, Damien; Lattuca, Benoit; Fauvel, Charles; Goralski, Marc; Alvain, Sean; Chaib, Aures; Piliero, Nicolas; Schurtz, Guillaume; Pommier, Thibaut; Bouleti, Claire; Tron, Christophe; Bonnet, Guillaume; Nhan, Pascal; Auvray, Simon; Léquipar, Antoine; Dillinger, Jean-Guillaume; Vicaut, Eric; Henry, Patrick; Toupin, Solenn; Pezel, Théo.
Affiliation
  • Hamzi K; Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, Assistance publique-Hôpitaux de Paris (AP-HP), 75010 Paris, France; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University H
  • Gall E; Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, Assistance publique-Hôpitaux de Paris (AP-HP), 75010 Paris, France; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University H
  • Roubille F; Inserm, CNRS, PhyMedExp, Cardiology Department, INI-CRT, Université de Montpellier, CHU de Montpellier, 34295 Montpellier, France.
  • Trimaille A; Department of Cardiovascular Medicine, Nouvel Hôpital Civil, Strasbourg University Hospital, 67000 Strasbourg, France.
  • Elbaz M; Intensive Cardiac Care Unit, Rangueil University Hospital, Toulouse, France.
  • El Ouahidi A; Department of Cardiology, University Hospital of Brest, 29609 Brest cedex, France.
  • Noirclerc N; Service de Cardiologie, Centre Hospitalier Annecy-Genevois, 74370 Épagny-Metz-Tessy, France.
  • Fard D; Intensive Cardiac Care Unit, University Hospital Henri-Mondor, Créteil, France.
  • Lattuca B; Department of Cardiology, Nîmes University Hospital, Montpellier University, Nîmes, France.
  • Fauvel C; Inserm U1096, Department of Cardiology, Université de Rouen-Normandie, CHU de Rouen, 76000 Rouen, France.
  • Goralski M; Service de Cardiologie, Centre Hospitalier d'Orleans, Orléans, France.
  • Alvain S; Service de Cardiologie, Centre Hospitalier de Saintes, Saintes, France.
  • Chaib A; Service de Cardiologie, Centre Hospitalier de Montreuil, Montreuil, France.
  • Piliero N; Service de Cardiologie, CHU de Grenoble-Alpes, Grenoble, France.
  • Schurtz G; Department of Cardiology, University Hospital of Lille, Lille, France.
  • Pommier T; Department of Cardiology, University Hospital, Dijon, France.
  • Bouleti C; Department of Cardiology, University Hospital of Poitiers, 86000 Poitiers, France.
  • Tron C; Inserm U1096, Department of Cardiology, Université de Rouen-Normandie, CHU de Rouen, 76000 Rouen, France.
  • Bonnet G; Inserm, Inrae, C2VN, Service de Cardiologie Interventionnelle, Aix-Marseille Université, CHU de Timone, AP-HM, Marseille, France.
  • Nhan P; Inserm UMR_S 938, Centre de Recherche Saint-Antoine, Institut Hospitalo-Universitaire de Cardiométabolisme et Nutrition (ICAN), Sorbonne Université, Paris, France; Service de Cardiologie, Hôpital Saint-Antoine, Assistance publique-Hôpitaux de Paris, Paris, France.
  • Auvray S; Department of Cardiology, Felix-Guyon University Hospital, Saint-Denis, Reunion.
  • Léquipar A; Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, Assistance publique-Hôpitaux de Paris (AP-HP), 75010 Paris, France; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University H
  • Dillinger JG; Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, Assistance publique-Hôpitaux de Paris (AP-HP), 75010 Paris, France; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University H
  • Vicaut E; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University Hospital of Lariboisière (AP-HP), 75010 Paris, France; Unité de Recherche Clinique, Hôpital Fernand-Widal, AP-HP, 75010 Paris, France.
  • Henry P; Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, Assistance publique-Hôpitaux de Paris (AP-HP), 75010 Paris, France; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University H
  • Toupin S; Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, Assistance publique-Hôpitaux de Paris (AP-HP), 75010 Paris, France; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University H
  • Pezel T; Inserm MASCOT - UMRS 942, Department of Cardiology, University Hospital of Lariboisière, Université Paris-Cité, Assistance publique-Hôpitaux de Paris (AP-HP), 75010 Paris, France; Department of Data Science, Machine Learning and Artificial Intelligence in Health, DATA-TEMPLE Laboratory, University H
Arch Cardiovasc Dis ; 117(6-7): 392-401, 2024.
Article in En | MEDLINE | ID: mdl-38834393
ABSTRACT

BACKGROUND:

Intensive cardiac care units (ICCUs) were created to manage ventricular arrhythmias after acute coronary syndromes, but have diversified to include a more heterogeneous population, the characteristics of which are not well depicted by conventional methods.

AIMS:

To identify ICCU patient subgroups by phenotypic unsupervised clustering integrating clinical, biological, and echocardiographic data to reveal pathophysiological differences.

METHODS:

During 7-22 April 2021, we recruited all consecutive patients admitted to ICCUs in 39 centers. The primary outcome was in-hospital major adverse events (MAEs; death, resuscitated cardiac arrest or cardiogenic shock). A cluster analysis was performed using a Kamila algorithm.

RESULTS:

Of 1499 patients admitted to the ICCU (69.6% male, mean age 63.3±14.9 years), 67 (4.5%) experienced MAEs. Four phenogroups were identified PG1 (n=535), typically patients with non-ST-segment elevation myocardial infarction; PG2 (n=444), younger smokers with ST-segment elevation myocardial infarction; PG3 (n=273), elderly patients with heart failure with preserved ejection fraction and conduction disturbances; PG4 (n=247), patients with acute heart failure with reduced ejection fraction. Compared to PG1, multivariable analysis revealed a higher risk of MAEs in PG2 (odds ratio [OR] 3.13, 95% confidence interval [CI] 1.16-10.0) and PG3 (OR 3.16, 95% CI 1.02-10.8), with the highest risk in PG4 (OR 20.5, 95% CI 8.7-60.8) (all P<0.05).

CONCLUSIONS:

Cluster analysis of clinical, biological, and echocardiographic variables identified four phenogroups of patients admitted to the ICCU that were associated with distinct prognostic profiles. TRIAL REGISTRATION ClinicalTrials.gov identifier NCT05063097.
Subject(s)
Key words

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenotype / Coronary Care Units Limits: Aged80 Language: En Journal: Arch Cardiovasc Dis Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2024 Document type: Article

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Phenotype / Coronary Care Units Limits: Aged80 Language: En Journal: Arch Cardiovasc Dis Journal subject: ANGIOLOGIA / CARDIOLOGIA Year: 2024 Document type: Article